INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
4.560
-0.150 (-3.18%)
At close: Nov 20, 2024, 4:00 PM
4.300
-0.260 (-5.70%)
After-hours: Nov 20, 2024, 5:10 PM EST
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $101.11 million as of November 21, 2024. Its market cap has decreased by -21.31% in one year.
Market Cap
101.11M
Enterprise Value
70.47M
1-Year Change
-21.31%
Ranking
Category
Stock Price
$4.56
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has increased from $77.82M to $101.11M, an increase of 29.92%. That is a compound annual growth rate of 4.62%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Century Therapeutics | 108.84M |
Akoya Biosciences | 107.06M |
Fractyl Health | 105.34M |
Inovio Pharmaceuticals | 105.18M |
Quipt Home Medical | 104.85M |
Leap Therapeutics | 103.31M |
Tiziana Life Sciences | 100.43M |
Anixa Biosciences | 100.40M |